Bioherent in an equity deal with Axon Partners Group, Bullnet Capital and CDTI-Innvierte.
07 July 2025
07 July 2025
Total investments received (USD): 2.3M
Round value (USD): 2.3M
Company: Bioherent
Related deals
Aptadel Therapeutics closed a €2 million bridge funding round with Newsight Tech Angels and Little Warrior Foundation
Investments
02 March 2026
D-Sight raised €2M with Clave Capital, Bio Angels Club and ICF - Institut Català de Finances in SPain
Investments
05 February 2026
Atlas Molecular Pharma closed a €3 million deal led by Inveready, joined by CDTI, Grupo SPRI, Kereon Partners, Endometrial DIDI, and CRB Inverbio
Investments
04 January 2026
Adaptam Therapeutics raised a €3 million pre-seed financing round led by Criteria Bio Ventures.
Investments
13 October 2025
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
United Kingdom